Assuming all HemoStase orders are timely received, what is CryoLife projecting for HemoStase sales for calendar years 2010, 2011, 2012, and 2013?
Note: In this regard it is my understanding that David Ashley Lee recently discussed these numbers, at some level, while testifying in Federal District Court in Atlanta. Presumably, it was David Ashley Lee’s HemoStase revenue projections that formed the basis for Medafor then asking for a $40 million bond in the event that the injunction was granted. Accordingly, this is a valid question and, assuming that the CryoLife Board is meeting its obligation to CryoLife’s shareholders, this information should be disclosed.
If my information here is in any way incorrect, then please explain what it was exactly that David Ashley Lee did say while on the stand in Federal District Court.
Anyone able to obtain a transcript of his testimony?